Evidence map›Paper›PMID 35891718›Full record

ArticleArchives of Razi Institute2022

Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19.

N H Abdulsada Al-Ghuraibawi, S Zeki Al-Fadhel, D M Mohammed Ali, H Kadhem Al-Hakeim

Open access · greenAbstract read
In one paragraph

Article in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

N H Abdulsada Al-GhuraibawiDepartment of Pharmacology, College of Pharmacy, University of Kufa, Kufa, Iraq.
S Zeki Al-FadhelDepartment of Clinical Laboratory Science, College of Pharmacy, University of Kufa, Kufa, Iraq.
D M Mohammed AliDepartment of Biochemistry, College of Medicine, University of Kufa, Kufa, Iraq.
H Kadhem Al-HakeimDepartment of Chemistry, College of Science, University of Kufa, Kufa, Iraq.
University of Kufa · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cigarette smoking is a risk factor associated with different diseases, claiming millions of lives annually. Smoking status has been studied for a long time and proved to be a major cause of smokers' decreased immunity. In the present pandemic COVID-19 disease, there was an unclear belief about the effect of smoking on patients with COVID-19. Therefore, the current cross-sectional study aimed to evaluate the effect of cigarette smoking on the sequelae of COVID-19. This cross-sectional study involved 200 COVID-19 patients (114 males and 86 females) aged 13-77 years. A number of 87 patients were smokers, and the rest of them were non-smokers. All patients underwent a comprehensive laboratory assessment and diagnosis by full medical history by the physicians. The results indicated a significant difference (

Indexed as

COVID-19Non-SmokersSmokersAdolescentAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk FactorsSmokingYoung AdultCigarette smokingCOVID-19Non-smokersSmokers

Identifiers

PMID35891718
PMCPMC9288610
OpenAlexW4288213310

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.